2024 Speakers

this event has run!

Alan Wahl
7
10
Bruce Keyt
Chris Gagliardi

Alan Wahl

Chief Executive Officer

Abacus Bioscience

Albert Hsia

Executive Director, Business Development

Merck

Brian Freed

Chief Scientific Officer

Rhuemagen

Bruce Keyt

Chief Scientific Officer

IGM Biosciences

Chris Gagliardi

Principal

Sanofi Venture

Daniel Parisotto
Donmienne Leung
Emma Smith
Frank Brennan
Hussein Al-Mossaiwi

Daniel Parisotto

Managing Director

Oppenheimer & Co

Donmienne Leung

Director AbbVie Ventures

AbbVie

Emma Smith

Head of Immune Reset

UCB

Frank Brennan

Head of Immunology Translation

UCB

Hussein Al-Mossaiwi

Vice President Research Immunology

Immunocore

Jonathan Zombeck
Jordan Zwick
Julia Manasson
Julie Di Paolo
1

Jonathan Zombeck

Director Business Development

Visterra, an Otsuka Company

Jordan Zwick

Chief Business Officer

Mirador Therapeutics

Julia Manasson

Medical Director

Seismic Therapeutic

Julie Di Paolo

Senior Director, Immunology Scientific Innovation Lead

Johnson & Johnson

Julien Genovino

Associate Director, Global Business Development & Strategy

Otsuka

Kalpana Gupta
Kevin White
Luke Henry
Mohamed Khobreh
Melissa Matzelle

Kalpana Gupta

Head of Immunology, Infectious Diseases & Metabolism Partnering

Regeneron

Kevin White

Head of Immune Tolerance  Therapeutics Discovery

AbbVie

Luke Henry

Chief Business Officer

Quell Therapeutics

Mohammad Khobreh

Managing Partner & Co-Founder

NG Bio

Melissa Matzelle

Director, Immunology Search & Evaluation

AbbVie

Neel Desai
Nicola La Monica
paul andrews
saifur rahman
Sean Evans

Neel Desai

Executive Director, Business Development

Biogen

Nicola La Monica

Senior Director, Strategic Search & Evaluation

Johnson & Johnson

Paul Andrews

Director, External Innovation

Biogen

Saifur Rahman

Director, Business Development & Licensing

Sanofi

Sean Evans

Senior Associate Venture Investments

Johnson & Johnson

Swarna Balasubramanian
Tatiana Ort
Tony Arulanandam
adil
alan

Swarna Balasubramanian

Associate Director, Search & Evaluation, Respiratory & Immunology

AstraZeneca

Tatiana Ort

Head of Bioscience Immunology

AstraZeneca

Tony Arulanandam

Chief Executive Officer & Founder

Synaptimmune Therapeutics

Adil Doganay

Director of Business Development

Glycostem

Alan Fu

Executive Vice President & Chief Financial Officer

IASO Biotechnology

nick
vikas
ross
John Mayfield
Naresh

Nick Veomett

Vice President Corporate Development & AlloNK Program Lead

Artiva Biotherapeutics

Vikas Goyal

Venture Partner

Longwood Fund

Ross Castillo

Principal, Biotech Private Investments

Wellington Management

John Mayfield

Senior Vice President, Business Development & Strategy

Flagship Pioneering

Naresh Kumar

Director Bioscience Immunology

AstraZeneca

Roly
Shanshan

Roly Foulkes

Chief Scientific Officer

Revolo Biotherapeutics

Shanshan Xu

Chief Executive Officer

Bambusa Therapeutics